Increasing Access to Breast Cancer Screening Among Immigrants

NCT04672265 | Active Not Recruiting

• 2 other identifiers: 19/218213396
• Study Type: interventional
• Target: 11,355
• Locations: 1 country
• Sites: 1

Brief Summary

The investigators aim to test whether inviting immigrants to breast cancer screening with a letter in their mother tongue in addition to the standard letter in Norwegian changes screening uptake in these immigrant groups, compared with a comparable group who receive the invitation in Norwegian only,

Conditions

Cancer Screening

Keywords

cancer screening; breast cancer; non-native; immigrant; participation rate; invitation; information

Outcome Measures

Primary Outcomes (1)

• Screening attendance

  Attendance in breast cancer screening programme (yes/no)

  0-6 months after sent screening invitation letter

Study Arms (2)

Mother tongue and Norwegian

EXPERIMENTAL

Written material related to screening sent to the invitee in two languages.

Other: Mother tongue and Norwegian

Norwegian

NO INTERVENTION

Written material related to screening sent to the invitee in Norwegian only.

Interventions

Mother tongue and Norwegian OTHER

The screening invitation letter, the information leaflet, the reminder letter and the result letter will be sent in two languages; an official language in the country where the invitee is born, and Norwegian.

Mother tongue and Norwegian

Eligibility Criteria

• Age: 48 Years - 73 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Invited to screening program during the study recruitment period (January 2021-June 2022)
• The registered country of birth of the invitee is one of the following; Poland, Pakistan, Philippines, Somalia, Iraq, Syria, Morocco, Lebanon, Algeria, Egypt, Palestine, Sudan and Tunisia

You may not qualify if:

• Not reached with the screening invitation letter because of wrong address or similar

Sponsors & Collaborators

• Oslo University Hospital: lead

Study Sites (1)

Oslo University Hospital, Cancer Registry

Oslo, 0304, Norway

Location

Related Publications (1)

• Hofvind S, Iqbal N, Thy JE, Mangerud G, Bhargava S, Zackrisson S, Berstad P. Effect of invitation letter in language of origin on screening attendance: randomised controlled trial in BreastScreen Norway. BMJ. 2023 Sep 19;382:e075465. doi: 10.1136/bmj-2023-075465.

  PMID: 37726122 DERIVED

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Officials

• Paula Berstad, PhD

  Norwegian Institute of Public Health

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Masking Details: The screening invitees randomized to the control group are not informed about this study. They receive "care as usual", the screening invitation letter in Norwegian language.
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Researcher

Model Details: Participants are randomized to receive the invitation in the major official native language in the country the participant is born and Norwegian, or in Norwegian only, consecutively when it is their turn to be invited to screening.

Study Record Dates

• First Submitted: November 16, 2020
• First Posted: December 17, 2020
• Study Start: April 15, 2021
• Primary Completion: August 31, 2022
• Study Completion (Estimated): December 31, 2030
• Last Updated: April 3, 2024

Record last verified: 2024-04

Data Sharing

• IPD Sharing: Will not share

Locations

NO (1)